info@quantimol.com - 1 (800) 821-7314 - Research Use Only - B2B & B2G Only - Not For Private Use
SKU:QM-0144715-01
Couldn't load pickup availability
Eribulin (E7389) is a microtubule targeting agent that is used for the research of metastatic breast cancer. Eribulin inhibits the proliferation of cancer cells by binding microtubule proteins and microtubules.
[253128-41-5]
C40H59NO11
729.9
C=C1C[C@@](CC[C@@]2(C[C@@]3([H])O4)O[C@]([C@](O[C@](C5)([H])CC6)([H])[C@@]6([H])O7)([H])[C@@]4([H])[C@]7([H])[C@@]3([H])O2)([H])O[C@@]1([H])CC[C@](C[C@@H](C)C8=C)([H])O[C@]8([H])C[C@@](O[C@H](C[C@H](O)CN)[C@@H]9OC)([H])[C@]9([H])CC5=O
ADC Payload; Apoptosis; Microtubule/Tubulin
99.92
DMSO : 200 mg/mL (ultrasonic)
-20°C (Powder, protect from light, stored under nitrogen)
Blue Ice
H301+H311+H331, H341, H351, H361
Loading...
Total items
Product subtotal
Eribulin is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.